Community

Nicolas Poirier, Ph.D.

Chief Scientific Officer, OSE Immunotherapeutics

Nicolas Poirier, Ph.D. is the Chief Scientific Officer at OSE Immunotherapeutics. He has about 15 years of experience in preclinical and translational development in biotechnology and partnership with pharmaceutical companies. He was awarded the Thesis Prize of the journal Le Monde. Nicolas Poirier has been chief scientific officer of OSE Immunotherapeutics since 2016. He joined the company in 2009 as project leader and then as director of scientific programs. Nicolas holds a Ph.D. in immunology and has a strong expertise in the development of immunotherapies. His role at OSE has been to implement innovative therapeutic strategies on new targets and pathways in immunology addressing severe pathologies with high therapeutic need, thus making a robust contribution to the Company’s growth. Along with his R&D team, Dr. Poirier continues pursuing the identification of novel preclinical targets and translating them into first-class clinical-stage immunotherapies. He is the author of several high-level international publications and patents in the area of immunotherapy.

Contributions

Q: How have evolving technologies like artificial intelligence (AI) and machine learning (ML) changed how you conduct research, manufacturing, or business?